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RNA splicing: Unexpected spliceosome diversity
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A novel form of spliceosome, containing the minor
snRNPs U11 and U12, splices a class of pre-mRNA
introns with non-consensus splice sites. This unexpected
spliceosome diversity has interesting implications for the
evolution and expression of eukaryotic genes.
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The discovery that most protein-coding genes in eukary-
otes are interrupted by one or more intervening
sequences, or introns, was one of the major advances in
molecular biology made in the 1970s [1,2]. The formation
of mRNA thus involves a splicing process to remove
introns from primary gene transcripts. Splicing takes
place in the nucleus before the mRNAs are exported to
the cytoplasm for translation and occurs by a two-step
mechanism, in which both steps involve transesterifica-
tion reactions [3]. The first step generates a free 5′ exon
and a ‘lariat’ form of the intron still attached to the 3′
exon as reaction intermediates. The lariat contains a
branched RNA structure that arises through the esterifi-
cation of the 5′ end of the intron to a 2′ ribose hydroxyl of
an adenosine residue located usually 20–40 nucleotides
upstream of the 3′ end of the intron. The second catalytic
step results in the ligation of the exons and release of the
lariat intron.
Although introns vary enormously in size and structure,
sequence comparisons have shown that conserved ele-
ments are present at their respective 5′ and 3′ splice sites
(Fig. 1). This includes a short consensus sequence at each
exon–intron junction, and additional elements called the
polypyrimidine tract and the branch site, usually located
immediately upstream of the 3′ splice site. The branch
site contains the adenosine residue with the 2′ hydroxyl
group used to form the lariat. Although in yeast, where the
density of introns is relatively low, consensus splice-site
sequences are well conserved, in higher eukaryotes this
conservation is much less pronounced and the primary
sequences of intron motifs vary considerably. In the vast
majority of introns, however, the first two nucleotides are
GT and the last two nucleotides AG.
Detailed biochemical studies in many laboratories have
shown that both catalytic steps of the splicing reaction
take place within a large RNA–protein complex termed a
spliceosome [3]. The major subunits of spliceosomes are
highly conserved, and correspond to the U1, U2, U4/U6
and U5 small nuclear ribonucleoprotein particles
(snRNPs). Each snRNP comprises one or two small
nuclear RNAs (snRNAs), a set of common Sm proteins
and a set of specific proteins. These snRNPs, together
with additional non-snRNP protein splicing factors,
assemble on a pre-mRNA substrate in a stepwise pathway
to form the active spliceosome. 
The conserved intron splice-site sequences are recognized
by the snRNPs and protein splicing factors during spliceo-
some assembly, both through protein–RNA interactions
and through snRNA–pre-mRNA base pairing. These
interactions specify precisely which phosphodiester bonds
will be cleaved and ligated, and mediate the folding of the
intron to bring these sites into close spatial alignment.
Until recently it was believed that the U1, U2, U4/U6 and
U5 snRNPs, along with some of the additional protein
splicing factors, formed a common core spliceosome
machinery required for the splicing of all nuclear pre-
mRNA introns. Now this view has been overturned by the
unexpected discovery of a novel form of spliceosome that
removes a specific class of introns.
There is a minor class of introns that lack the conserved
splice-site sequences [4,5]. Instead, these introns share a
distinct set of conserved elements (Fig. 1). Thus, their 5′
Figure 1
Conserved elements in mammalian GT–AG and AT–AC introns. The
first and last two nucleotides of the introns are shown in bold and the
branch-site adenosine residue that forms the lariat structure is marked
by an asterisk. The polypyrimidine tract that lies between the branch
site and 3′ intron–exon junction of GT–AG introns is lacking in AT–AC
introns. The sites of cleavage at the 5′ and 3′ splice sites are indicated
by red arrows.
GT–AG intron
AT–AC intron
AG GTRAGT TNCTRAC Py CAG G
ATATCCTT TCCTTAAC YCCAC
5' splice site Branch site 3' splice site
5' splice site Branch site 3' splice site
© 1996 Current Biology
*
*
Dispatch 803
ends start with AT instead of the usual GT, and their 3′
ends have AC in place of AG. We shall therefore refer to
the minor and major classes of introns as ‘AT–AC’ and
‘GT–AG’ introns, respectively. AT–AC introns also lack
the characteristic polypyrimidine tract found near the 3′
end of GT–AG introns, and show strong conservation of
the branch-site region. So far, AT–AC introns have been
found in four different genes and occur both in flies and
mammals (Table 1). In the case of the P120 gene, which
encodes a proliferation-associated nucleolar protein, an
AT–AC intron is conserved between human, monkey, dog
and mouse [5]. Interestingly, AT–AC and GT–AG introns
can occur simultaneously in a single gene and, in the case
of the Drosophila prospero gene, an GT–AG intron is
reportedly found entirely within an AT–AC intron [5].
During splicing of GT–AG introns, the U1 and U2
snRNPs make essential base-pairing interactions with the
5′ intron–exon junction and branch site, respectively.
How, then, can AT–AC introns be recognized and spliced
by the same machinery, when their splice-site sequences
differ so dramatically from the GT–AG consensus that one
would not expect them to be able to interact stably with
U1 and U2 snRNAs? An intriguing potential solution to
this dilemma was proposed by Hall and Padgett [5], who
pointed out that two minor nuclear snRNAs, U11 and
U12, have regions of sequence complementarity to the 5′
end and the branch site of AT–AC introns. The U11 and
U12 snRNPs had previously been identified as minor
nuclear snRNPs of unknown function, which also contain
the common Sm proteins present in spliceosomal snRNPs
[6]. Hall and Padgett [5] suggested that U11 and U12
snRNPs may be involved in splicing AT–AC introns,
where they would substitute for the roles U1 and U2
snRNPs play in the splicing of GT–AG introns. Two
recent studies have now provided dramatic confirmation
of this proposal [7,8].
To analyse splicing of AT–AC introns in vivo, Hall and
Padgett [7] expressed a fragment of the human P120 gene
containing a 99-nucleotide long AT–AC intron in CHO
cells, using a transient transfection assay. The transiently
expressed AT–AC intron is correctly spliced in the trans-
fected CHO cells. However, an AT–AC intron in which
two nucleotides in the proposed branch-site consensus
element were mutated was not spliced. Changing these
two nucleotides would be expected to impair base pairing
of U12 snRNA at the branch site, but not any potential
base pairing to U2 snRNA (Fig. 2). This result supports
the view that base pairing to U12, rather than U2, snRNA
is involved in splicing the P120 intron. Importantly, Hall
and Padgett [7] also showed that splicing could be
rescued by co-transfection with a construct encoding a
version of U12 snRNA with substitutions that restore the
potential for base pairing with the mutated AT–AC intron
branch site. This in vivo suppression provides a clear
demonstration that U12 snRNP functions in the splicing
of AT–AC introns.
A major breakthrough in the analysis of AT–AC introns
has come with the development by Tarn and Steitz [8] of
a system for splicing them in vitro. They started with stan-
dard HeLa nuclear splicing extracts, which accurately
splice conventional GT-AG introns but were found not to
process correctly an AT–AC intron from the human P120
gene. Tarn and Steitz [8] found that the extracts were able
to splice the AT–AC intron after inactivation of U2
snRNA, using an anti-U2 snRNA oligonucleotide, condi-
tions under which splicing of a GT–AG intron was inhib-
ited. Conversely, an antisense oligonucleotide targeted to
U12 snRNA prevented splicing of the AT–AC intron, but
not of a GT–AG intron. These in vitro data [8] are there-
fore consistent with the results from the in vivo studies in
Table 1
Eukaryotic genes containing an AT–AC introns.
Gene Species Gene product
CMP (intron G) Human/chicken Cartilage matrix protein
Rep-3 Mouse Mismatch repair protein
P120 Human/monkey/dog/mouse Nucleolar protein
prospero Drosophila Homeobox protein
A compilation of known AT–AC introns, indicating the genes and
organisms in which they have been found and the type of protein they
encode.
Figure 2
Potential base pairing interactions between the branch site of the
human P120 AT–AC intron and U12 or U2 snRNAs. The adenosine
residue that forms the lariat structure is marked by an asterisk and
shown bulged from the putative intron–snRNA hybrid. Possible base
pairings are indicated by vertical lines. The sites in the P120 intron
where mutations inhibit splicing in vivo are marked in bold, as are the
corresponding two sites in U12 snRNA where compensatory
mutations that restore the potential for base pairing suppress the
splicing defect [7].
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CHO cells [7], and indicate that U12 snRNP is specifically
required for splicing of AT–AC introns.
Characterization of the in vitro splicing reaction indicated
that, like splicing of GT–AG introns, splicing of AT–AC
introns proceeds via a two-step mechanism, including the
formation of a branched intron-lariat intermediate [8]. The
predicted sites of 5′ cleavage and branch formation were
confirmed by primer extension analyses, and the accuracy
of the splicing reaction confirmed by amplification and
sequencing of the spliced mRNA product, using the poly-
merase chain reaction (PCR). In addition, psoralen
crosslinking studies provided direct physical evidence that
U12 snRNA base pairs with the AT–AC intron at the
branch site. Interestingly, U2 snRNA also base pairs with
the AT–AC intron, unless inhibited by the anti-U2
snRNA oligonucleotide [8]. This indicates that, at least in
the context of the in vitro system, there is competition
between U2 and U12 snRNPs for binding to the AT–AC
intron. As U2 snRNP is much more abundant than U12
snRNP in HeLa nuclear extracts, this competition may
explain why AT–AC splicing is not observed unless U2
snRNP is inhibited.
Tarn and Steitz [8] have characterized, using a native gel
electrophoresis assay, the assembly pathway and snRNP
composition of spliceosomes formed on the AT–AC
intron, and compared this with spliceosomes formed on
GT–AG introns. The major differences were the slower
kinetics of formation of the AT–AC ‘C complex’, which
contains reaction intermediates and products, and in the
types of snRNP present. Some differences were also seen
in the pattern of faster migrating complexes formed on the
two types of intron, although the significance of this is at
present unclear. The only snRNP common to both
AT–AC and GT–AG spliceosomes was U5 snRNP. As an
antisense oligonucleotide directed against U5 snRNA
inhibited splicing of both AT–AC and GT–AG introns, it
appears that U5 snRNP is a functional component of both
types of spliceosome.
The U12 snRNP was detected in all the specific com-
plexes formed on the AT–AC intron, but not in those
formed on the GT–AG intron. In contrast, U11 snRNP
was not detected in the AT–AC C complex, but was
present in the faster migrating A1 complex, which is
believed to be a precursor of the active spliceosome.
Neither the U4 nor U6 snRNAs, which are both present
in GT–AG spliceosomes, were detected in any of the
complexes formed on the AT–AC intron [8]. As an anti-
sense oligonucleotide directed against the U6 snRNA
inhibited splicing of the GT–AG intron, but not of the
AT–AC intron, it appears U6 snRNA is not required for
AT–AC splicing. This is somewhat surprising, as U6
snRNA shows the highest level of conservation of all the
spliceosomal RNAs, and has been widely speculated to
play a direct role in catalysis [9]. An interesting possibility
is that one or more additional snRNAs, yet to be identi-
fied, are present in the AT–AC spliceosome and take
over the functions normally provided by U4 and/or U6
snRNAs. It cannot be excluded, however, that splicing of
AT–AC introns simply does not require the function
provided by U4/U6 snRNAs.
The new results on the splicing of AT–AC introns clearly
represent an important discovery in the splicing field.
They provide the first demonstration that distinct splicing
machines are involved in the removal of different types of
pre-mRNA intron. It will be very important now to charac-
terize in detail the RNA and protein composition of
AT–AC spliceosomes. This could identify other minor
snRNAs as splicing factors and will reveal how many com-
ponents are shared by the two machineries. Compelling
evidence has been provided that the U12 snRNP func-
tionally substitutes for U2 snRNP in the splicing of
AT–AC introns [7,8]. It also seems likely that U11 snRNP
substitutes for U1 snRNP, as proposed by Hall and
Padgett [5]. At least in the in vitro system, U1 snRNP is
not required for the splicing of AT–AC introns [8].
However, direct experimental proof, either in vivo or in
vitro, that U11 snRNP is required for AT–AC splicing
remains to be provided.
That the basic two-step splicing mechanism is common to
both intron classes, and U5 snRNP is a functional compo-
nent of both spliceosomes, strongly indicates that the
introns have arisen from a common ancestor. Therefore,
any components required for splicing of both types of
intron could offer important clues about critical inter-
actions at the heart of the splicing reaction. As AT–AC
introns are present in both flies and mammals, they must
have been present before the evolution of vertebrates.
The discovery of AT–AC introns also raises the interest-
ing possibility that additional types of intron exist, which
are also spliced by specialized machineries. Also, the exis-
tence of distinct spliceosome classes could allow gene
expression to be regulated by modulating splicing factors
required only by introns of a specific class. We speculate
that this may prove to be important for regulating gene
expression in highly differentiated tissues, such as
neurons, where alternative RNA splicing is prevalent.
The much greater abundance of the major spliceosomal
snRNPs, which splice GT–AG introns, than minor
snRNPs, such as U11 and U12, presumably reflects the
much greater abundance of GT–AG over AT–AC introns.
Assuming that the two intron classes arose from a common
ancestor, it is unclear why one class is now so much more
abundant than the other. It is quite likely that other
AT–AC introns exist which have not yet been identified.
The stream of information currently emerging from
genomic sequencing projects will provide a valuable
resource for searching chromosomal sequences for new
AT–AC introns and for other classes of introns with non-
consensus splice sites. This should lead to more important
insights concerning the structure and expression of
nuclear genes and should help to clarify just how diverse
the pre-mRNA splicing machinery can be.
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